Director, Small Molecule Neurotherapeutic Development
National Institute of Neurological Disorders and Stroke (NINDS) is a leading supporter of biomedical research on disorders of the brain and the nervous system at the National Institutes of Health (NIH). NINDS leads two major trans-NIH programs to support early translational efforts in therapeutics discovery and development - Blueprint Neurotherapeutics Network (BPN) and Helping End Addiction Long-term (HEAL) Pain Therapeutics Development program (PTDP) to advance the NIH mission and therapeutics discoveries towards clinical trials and ultimately patient use.
Located within the Division of Translation Research (DTR), the Director, Small Molecule Neurotherapeutic Development is intended to oversee BPN and PTDP to create significant synergy and efficiently accelerate therapeutics development designed to prevent and treat CS disorders and pain that is focused on the academic and small business community and is cost effective. The Director exercises broad influence regarding highly complex neurotherapeutics development and policy issues and provides leadership such as the following:
- provide sound judgement on stage appropriate risk for NIH investments in neurotherapeutics development projects as well as appropriate data driven discontinuation decisions in a timely manner;
- manage a portfolio of neurotherapeutics development projects spanning from early discovery to late development;
- direct and influence teams to remain focused on critical path execution of milestone objectives in a timely fashion and within budget;
- present the programs to the Extramural Community and presents on the programs at National Meetings as well as targeted foundations, webinars, and other forums;
- supervise staff involved in programs related to the neurotherapeutics development at NINDS.
Applicants must possess a Ph.D. or equivalent doctoral degree, substantial multidisciplinary scientific expertise in small molecule neurotherapeutics development with experience advancing research ideas to the point of helping patients. The ideal candidate will have programmatic experience working with academia and industry and be a recognized expert in neurotherapeutics preclinical development, product optimization, preclinical scale up and manufacture and toxicology, regulatory affairs, and early human clinical trials. The incumbent will also have a history of neurotherapeutics development for distinction with scientific awards, working with relevant professional societies, and being invited lectures and at major meetings and symposia.
The position will be filled under a Senior Biomedical Research and Biomedical Product Assessment Services (SBRBPAS) excepted service appointment. Salary is commensurate with the experience and a full package of Civil Service benefits is available, including retirement, health and life insurance, leave, and savings plan (401K equivalent).
How to Apply: Please submit your cover letter, CV, and contact details for three references and include “Small Molecule Neurotherapeutic Development” on the Subject Line. Specific questions regarding this vacancy can be directed to DTRRecruitments@nih.gov. Your application package must be received by July 25, 2021.
All information provided by candidates will remain strictly confidential and will not be released outside the search process without a signed release from candidates. HHS and NIH are Equal Opportunity Employers.